VEGF and VEGF type C play an important role in angiogenesis and lymphangiogenesis in human malignant mesothelioma tumours

British Journal of Cancer

Volumn 81, Issue 1, 1999, Pages 54-61

  Ohta, Y ^a,c   Shridhar, V ^a   Bright, R K ^a   Kalemkerian, G P ^a   Du, W ^a   Carbone, M ^b   Watanabe, Y ^c   Pass, H I ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Loyola Hines Dept of Radiotherapy   (United States)

^c KANAZAWA UNIVERSITY   (Japan)

Author keywords

Angiogenesis; Lymphangiogenesis; malignant mesothelioma; Vascular endothelial growth factor; VEGF; VEGF C

Indexed keywords

5' NUCLEOTIDASE; BLOOD CLOTTING FACTOR 8; MESSENGER RNA; PROTEIN TYROSINE KINASE; VASCULOTROPIN; VASCULOTROPIN RECEPTOR;

ANGIOGENESIS; ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; DENSITY; ENZYME INHIBITION; HISTOCHEMISTRY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; LYMPH VESSEL; LYMPHANGIOMA; MALIGNANT MESOTHELIOMA; MICROVASCULATURE; PLEURA; PLEURA MESOTHELIOMA; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

5'-NUCLEOTIDASE; ENDOTHELIAL GROWTH FACTORS; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHATIC SYSTEM; LYMPHOKINES; MESOTHELIOMA; NEOVASCULARIZATION, PATHOLOGIC; PLEURA; PLEURAL NEOPLASMS; PROTO-ONCOGENE PROTEINS; RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTORS, GROWTH FACTOR; RECEPTORS, VASCULAR ENDOTHELIAL GROWTH FACTOR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; STAINING AND LABELING; TUMOR CELLS, CULTURED; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0032829875     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6690650     Document Type: Article

References (33)

1. Airas L, Niemela J, Salmi M, Puurunen T, Smith DJ and Jalkanen S (1997) Differential regulation and function of CD73, a glycosyl-phosphatidylinositol-linked 70-kD adhesion molecule, on lymphocytes and endothelial cells. J Cell Biol 136: 421-431
2. Canbolat O, Durak I, Cetin R. Kavutcu M, Demirci S and Ozturk S (1996) Activities of adenosine deaminase, 5′-nucleotidase, guanase, and cystidine deaminase enzymes in cancerous and non-cancerous human breast tissues. Breast Cancer Res Treat 189-193
3. Chodak GW, Haudenschild C, Gittes RF and Folkman I (1980) Angiogenic activity as a marker of neoplasia and prencoplasia in lesions of the human bladder. Ann Surg 192: 762-771
4. Durak I, Beduk Y, Kavuteu M, Suzer O, Yaman O, Ozturk HS, Canbolat O and Ulutepe S (1997) Activity of the enzymes participating in purine metabolism of cancerous and non-cancerous human kidney tissues. Cancer Invest 5: 212-216
5. Folkman J (1990) What is the evidence that tumors are angiogenesis dependent? J Natl Cancer Inst 82: 4-6
6. Folkman J (1995) Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med 1: 27-31
7. Grimmond S, Lagercrantz J, Drinkwater C, Silins G, Townson S, Pollock P, Gotley D, Carson E, Rakar S, Nordenskjold M, Ward L, Hayward N and Weber G (1996) Cloning and characterization of a novel human gene related to vascular endothelial growth factor. Genome Res 6: 124-131
8. Hewett PW and Murray JC (1996) Coexpression of flt-1, flt-4 and KDR in freshly isolated and cultured human endothelial cells. Biochem Biophys Res Commun 221: 697-702
9. Jeltsch M, Kaipainen A, Joukov V, Meng X, Lakso M, Rauvala H, Swartz M, Fukumura D, Jain RK and Alitalo K (1997) Hyperplasia of lymphatic vessels in VEGF-C transgenic mice. Science 276: 1423-1425
10. Ji RC and Kato S (1997) Enzyme histochemical study on postnatal development of rat stomach lymphatic vessels. Microvasc Res 54: 1-12
11. Joukov V, Pajusola K, Kaipainen A, Chilov D, Lahtinen I, Kukk E, Saksela O, Kalkkinen N and Alitalo K (1996) A novel vascular endothelial growth factor, VEGF-C, is a ligand for the flt-4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases. EMBO J 15: 290-298
12. Kaipainen A, Korhonen J, Mustonen T, van Hinsbergh VWM, Fang G, Dumoni D, Breitman M and Alitalo K (1995) Expression of the fms-like tyrosine kinase 4 gene becomes restricted to lymphatic endothelium during development. Proc Natl Acad Sci USA 92: 3566-3570
13. Kukk E, Lymboussaki A, Taira S, Kaipainen A, Jeltsch M, Joukov V and Alitalo K (1996) VEGF-C receptor binding and pattern of expression with VEGFR-3 suggests a role in lymphatic vascular development. Development 122: 3829-3837
14. Kumar-Singh S, Vermeulen PB, Weyler J, Segers K, Weyn H, van Dacle A, Dirix LY, van Oosterom AT and van Marck E (1997) Evaluation of tumour angiogenesis as a prognostic marker in malignant mesothelioma. J Pathol 182: 211-216
15. Lee J, Gray A, Yuan J, Luoh S, Avraham H and Wood WI (1996) Vascular endothelial growth factor-related protein: a ligand and specific activator of the tyrosine kinase receptor flt-4. Proc Natl Acad Sci USA 93: 1988-1992
16. Macchiarini P, Fontanini G, Hardin MJ, Squartini F and Angeletti CA (1992) Relation of neovascularization to metastasis of non-small-cell lung cancer. Lancet 340: 145-146
17. Mattern J, Koomagi R and Volm M (1995) Vascular endothelial growth factor expression and angiogenesis in non-small-cell lung carcinomas. Int J Oncol 6: 1059-1062
18. Meyer M, Clauss M, Lepple-Wienhues A, Waltenberger J, Augustin HG, Ziche M, Lanz C, Bittner M, Rziha HJ and Dehio C (1999) A novel vascular endothelial growth factor encoded by Orf virus, VEGF-E, mediates angiogenesis via signalling through VEGFR-2 (KDR) but not VEGFR-1 (Flt-1) receptor tyrosine kinase. EMBO J 18: 363-374
19. Mossman BT, Kamp DW and Weitzman SA (1996) Mechanisms of carcinogenesis and clinical features of asbestos-associated cancers. Cancer Invest 14: 466-480
20. Oh SJ, Jeltsch MM, Birkenhager R, McCarthy JE, Weich HA, Christ B, Alitalo K and Wilting J (1997) VEGF and VEGF-C: specific induction of angiogenesis and lymphangiogenesis in the differentiated avian chorioallantoic membrane. Dev Biol 188: 96-109
21. Olofsson B, Pajusola K, Kaipainen A, von Euler G, Joukov V, Saksela O, Orpana A, Pettersson RF, Alitalo K and Eriksson U (1996) Vascular endothelial growth factor B, a novel growth factor for endothelial cells. Proc Natl Acad Sci USA 93: 2576-2581
22. Pass HI, Stevens FJ, Oie H, Tsokos MG, Abati AD, Fetsch PA, Mew DJY, Pogrebniak HW and Matthews WJ (1995) Characteristics of nine newly derived mesothelioma cell lines. Ann Thorac Surg 59: 835-8344
23. Rusch VW (1996) A proposed new International TNM staging system for malignant pleural mesothelioma from the International Mesothelioma Interest Group. Lung Cancer 14: 1-12
24. Samoto K, Ikezaki K, Ono M, Shono T, Kohno K, Kuwano M and Fukui M (1995) Expression of vascular endothelial growth factor and its possible relation with neovascularization in human brain tumor. Cancer Res 55: 1189-1193
25. Takahashi Y, Kitadai Y, Bucana CD, Cleary KR and Ellis LM (1995) Expression of vascular endothelial growth factor and its receptor, KDR, correlates with vascularily, metastasis, and proliferation of human colon cancer. Cancer Res 55: 3964-3968
26. Toi M, Hoshina S, Takayanagi T and Tominaga T (1994) Association of vascular endothelial growth factor expression with tumor angiogenesis and with early relapse in primary breast cancer. Jpn J Cancer Res 85: 1045-1049
27. Turner RR, Beckstead JH, Warnke RA and Wood GS (1987) Endothelial cell phenotypic diversity. In situ demonstration of immunologic and enzymatic heterogeneity that correlates with specific morphologic subtypes. Am J Clin Pathol 87: 569-575
28. Vetter W (1970) Alkaline phosphatasen in mastzellen, blut-und lymphagefäβen der rattenzunge. 5′-nucleotidase-, unspezifische alkalische phosphatase-und polyphosphatase-(ATP'ase) aktivitäl unter besondere berückscichtigung des pH. Z Anat Entwicklungsgesh 130: 153-176
29. Wachstein M and Meisel E (1954) The histochemical distribution of 5-nucleotidase and unspecific alkaline phosphatase in the testicle of various species and in two human seminomas. J Histochem 2: 137-148
30. Weidner N, Semple JP, Welch WR and Folkman J (1991) Tumor angiogenesis and metastasis - correlation in invasive breast carcinoma. N Engl J Med 324: 1-8
31. Wilting J, Birkenhager R, Eichmann A, Kurz H, Martiny-Baron G, Marme D, McCarthy JE, Christ B and Weich HA (1996) VEGF121 induces proliferation of vascular endothelial cells and expression of flk-1 without affecting lymphathic vessels of chorioallantoic membrane. Dev Biol 176: 76-85
32. Wood GS, Beckstead JH, Turner RR, Hendrickson MR, Kempson RL and Warnke RA (1986) Malignant fibrous histiocytoma tumor cells resemble fibroblasts. Am J Surg Pathol 110: 323-335
33. Yamada V, Nezu J, Shimane M and Hirata Y (1997) Molecular cloning of a novel vascular endothelial growth factor. VEGF-D. Genomics 42: 483-488